Viewing nowTerbiclean Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 200500538 · Approved 2005.04.28 · Insurance code 694000580
Treatment of onychomycosis and tinea (e.g., tinea pedis and tinea capitis)
This medication is used to treat tinea pedis, tinea corporis, tinea cruris, and onychomycosis in adults due to skin fungal infections. It is effective for treating tinea capitis in children. It aids in the treatment of various skin fungal infections.
Administer terbinafine at a dose of 125 mg twice daily or 250 mg once daily. The treatment duration according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. For infections of the fingernails or relatively small toes, or in younger patients, the treatment duration may be shortened to 3 months or less. For toenail infections, 3 months of treatment is usually sufficient, but some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. For patients with creatinine clearance below 50 mL/min, reduce the daily dose by 1/2.
Administer to children aged 2 years or older. Administration is not recommended for children under 2 years of age because there is no experience with use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs primarily in children. To prevent recurrence of infection, treatment should be administered regularly for the prescribed duration. Body weight below 20 kg (under 5 years): Administer 62.5 mg once daily. Because experience with use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight over 40 kg (over 12 years): Administer 250 mg once daily.
This medication is not recommended for patients with chronic or active liver disease with poor liver function. Before administration, it is essential to check for a history of liver disease and liver function tests, and regular liver function tests should be performed during treatment. If symptoms of liver dysfunction appear, such as nausea, loss of appetite, fatigue, vomiting, pain in the upper right abdomen, jaundice, dark urine, or diarrhea, the physician must be informed immediately. If liver damage is suspected during the use of this medication, it should be discontinued immediately, and medical attention must be sought. This medication should not be administered to patients with blood disorders, severe renal failure, nursing mothers, infants under 2 years of age, and those with lactose intolerance. Particularly, patients with low white blood cell or platelet counts require caution. It should be used with caution in patients with impaired kidney function, the elderly, and children weighing less than 20 kg, and the treatment should be stopped if skin rashes or serious skin reactions occur. Patients with psoriasis or systemic lupus erythematosus need to be cautious when using this medication. This medication can cause various side effects in the liver, blood, skin, muscles, gastrointestinal tract, and nervous system; therefore, if any abnormal symptoms appear, they should be reported to medical personnel immediately. Caution is advised when driving or operating machinery as side effects such as dizziness may occur. This medication may interact with other drugs, so if any other medications are being taken, healthcare providers should be informed, especially if combined with drugs that affect liver metabolism, as dose adjustments may be necessary. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and nursing mothers should discontinue breastfeeding while taking it. Children and the elderly may metabolize and excrete the drug differently, so extra caution is required when using this medication. Overdose may result in symptoms such as headache, nausea, abdominal pain, dizziness, and appropriate medical treatment should be sought immediately.
Liver failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, phototoxic reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasiform rash, psoriasis exacerbation, alopecia, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, elevated myoglobin, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbances, dizziness, drowsiness, sensory disturbances, sensory decrease, decreased attention, insomnia, elevated BUN, polyuria, visual disturbances, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol in the blood, elevated triglycerides, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, hyposmia, drug rash accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.
White circular tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.